Modulation of voltage-dependent sodium channels by the δ-agonist SNC80 in acutely isolated rat hippocampal neurons

Neuropharmacology

Volumn 47, Issue 7, 2004, Pages 1102-1112

  Remy, Christina ^a   Remy, Stefan ^b   Beck, Heinz ^b   Swandulla, Dieter ^a   Hans, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Hippocampus; Opioids; SCN80; Slow inactivation; Sodium channel

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR AGONIST; NALOXONE; NALTRINDOLE; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CURRENT;

ALGORITHMS; ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; ENKEPHALIN, D-PENICILLAMINE (2,5)-; HIPPOCAMPUS; KINETICS; MALE; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; SODIUM CHANNELS;

EID: 8844255493     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.06.034     Document Type: Article

References (36)

1. Alekov A.K., Peter W., Mitrovic N., Lehmann-Horn F., Lerche H. Two mutations in the IV/S4-S5 segment of the human skeletal muscle Na+ channel disrupt fast and enhance slow inactivation. Neurosci. Lett. 306:2001;173-176
2. Bezanilla F., Armstrong C.M. Inactivation of the sodium channel. I. Sodium current experiments. J. Gen. Physiol. 70:1977;549-566
3. Bilsky E.J., Calderon S.N., Wang T., Bernstein R.N., Davis P., Hruby V.J., McNutt R.W., Rothman R.B., Rice K.C., Porreca F. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J. Pharmacol. Exp. Ther. 273:1995;359-366
4. Calderon S.N., Rice K.C., Rothman R.B., Porreca F., Flippen-Anderson J.L., Kayakiri H., Xu H., Becketts K., Smith L.E., Bilsky E.J., Davis P., Horvath R. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands. J. Med. Chem. 40:1997;695-704
5. Catterall W.A. Cellular and molecular biology of voltage-gated sodium channels. Physiol. Rev. 72:(Suppl.):1992;S15-S48
6. Christie M.J., Connor M., Vaughan C.W., Ingram S.L., Bagley E.E. Cellular actions of opioids and other analgesics: implications for synergism in pain relief. Clin. Exp. Pharmacol. Physiol. 27:2000;520-523
7. Colbert C.M., Magee J.C., Hoffman D.A., Johnston D. Slow recovery from inactivation of Na+ channels underlies the activity-dependent attenuation of dendritic action potentials in hippocampal CA1 pyramidal neurons. J. Neurosci. 17:1997;6512-6521
8. Cummins T.R., Sigworth F.J. Impaired slow inactivation in mutant sodium channels. Biophys. J. 71:1996;227-236
9. Ellerkmann R.K., Riazanski V., Elger C.E., Urban B.W., Beck H. Slow recovery from inactivation regulates the availability of voltage-dependent Na+ channels in hippocampal granule cells, hilar neurons and basket cells. J. Physiol. 532:2001;385-397
10. Fleidervish I.A., Gutnick M.J. Kinetics of slow inactivation of persistent sodium current in layer V neurons of mouse neocortical slices. J. Neurophysiol. 76:1996;2125-2130
11. Fleidervish I.A., Friedman A., Gutnick M.J. Slow inactivation of Na+ current and slow cumulative spike adaptation in mouse and guinea-pig neocortical neurones in slices. J. Physiol. 493:(Pt. 1):1996;83-97
12. Gaveriaux-Ruff C., Filliol D., Simonin F., Matthes H.W., Kieffer B.L. Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity. J. Pharmacol. Exp. Ther. 298:2001;1193-1198
13. Hayes S.R., Vogelsang J. Opiate receptors and analgesia: an update. J. Post Anesth. Nurs. 6:1991;125-128
14. + channels associated with myotonia and periodic paralysis. Biophys. J. 72:1997;1204-1219
15. Hung C.F., Tsai C.H., Su M.J. Opioid receptor independent effects of morphine on membrane currents in single cardiac myocytes. Br. J. Anaesth. 81:1998;925-931
16. Kieffer B.L. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20:1999;19-26
17. Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66:2002;285-306
18. Lehmann-Horn F., Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol. Rev. 79:1999;1317-1372
19. Marom S. Slow changes in the availability of voltage-gated ion channels: effects on the dynamics of excitable membranes. J. Membr. Biol. 161:1998;105-113
20. + channel gating between fast-spiking interneurones and principal neurones of rat hippocampus. J. Physiol. 505:1997;593-603
21. Massotte D., Kieffer B.L. A molecular basis for opiate action. Essays Biochem. 33:1998;65-77
22. Melamed-Frank M., Marom S. A global defect in scaling relationship between electrical activity and availability of muscle sodium channels in hyperkalemic periodic paralysis. Pflugers Arch. 438:1999;213-217
23. Mitrovic N., George A.L. Jr., Horn R. Role of domain 4 in sodium channel slow inactivation. J. Gen. Physiol. 115:2000;707-718
24. Ragsdale D.S., Avoli M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res. Brain Res. Rev. 26:1998;16-28
25. + currents in acutely isolated human hippocampal dentate granule cells. J. Physiol. 509:(Pt. 1):1998;139-150
26. Remy S., Urban B.W., Elger C.E., Beck H. Anticonvulsant pharmacology of voltage-gated sodium channels in hippocampal neurons of control and chronically epileptic rats. Eur. J. Neurosci. 17:2003;2648-2658
27. Ruben P.C., Starkus J.G., Rayner M.D. Steady-state availability of sodium channels. Interactions between activation and slow inactivation. Biophys. J. 61:1992;941-955
28. Rudy B. Slow inactivation of the sodium conductance in squid giant axons. Pronase resistance. J. Physiol. 283:1978;1-21
29. + channels. J. Gen. Physiol. 120:2002;509-516
30. Stühmer W., Conti F., Suzuki H., Wang X., Noda M., Yahagi N., Kubo H., Numa S. Structural parts involved in activation and inactivation of the sodium channel. Nature. 339:1989;597-603
31. Su X., Joshi S.K., Kardos S., Gebhart G.F. Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects. J. Neurophysiol. 87:2002;1271-1279
32. Toib A., Lyakhov V., Marom S. Interaction between duration of activity and time course of recovery from slow inactivation in mammalian brain Na+ channels. J. Neurosci. 18:1998;1893-1903
33. Vilin Y.V., Ruben P.C. Slow inactivation in voltage-gated sodium channels: molecular substrates and contributions to channelopathies. Cell Biochem. Biophys. 35:2001;171-190
34. West J.W., Patton D.E., Scheuer T., Wang Y., Goldin A.L., Catterall W.A. A cluster of hydrophobic amino acid residues required for fast Na(+)- channel inactivation. Proc. Natl. Acad. Sci. USA. 89:1992;10910-10914
35. Xiong W., Li R.A., Tian Y., Tomaselli G.F. Molecular motions of the outer ring of charge of the sodium channel: do they couple to slow inactivation? J. Gen. Physiol. 122:2003;323-332
36. Zou B., Chen Y., Wu C., Zhou P. Blockade of U50488H on sodium currents in acutely isolated mice hippocampal CA3 pyramidal neurons. Brain Res. 855:2000;132-136